About US
Contact us
-
conference Review: third LORENZ Connect conferenceLORENZ Connect 2022: Valuable RA insights for 380 attendees in 32 countries! Our third LORENZ Connect conference has come to an end. We would like to thank all of our speakers for the time and effor2022/5/27
-
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in convictionA federal investigation into a criminal ring that stole trade secrets from GlaxoSmithKline for a Chinese biotech has claimed its fifth target. Gongda Xue, a Chinesecitizen and former scientist2022/5/26
-
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launchesEver since Takeda closed its Shire takeover, the company has prioritized cutting its debt. After selling off some dispensable assets, the Japanese pharma is moving closer to its goal and is increasin2022/5/26
-
Merck KGaA lines up 370 new jobs with $470M manufacturing boost in IrelandGermany’s Merck KGaA—fresh off its buyout of mRNA player Exelead—is throwing down almost half a billion dollars more to grow its manufacturing footprint on the Emerald Isle. Merck KGaA will inv2022/5/24
-
Vir, WuXi Biologics terminate COVID antibody pact as US rollout faces uncertain futureThe U.S. distribution of Vir Biotechnology’s GSK-partnered COVID-19 antibody has been put on hold for more than a month. Now, a collaborator in the therapy wants out. WuXi Biologics has returne2022/5/24
-
Quickly turning $23M into $10M, Zealand offloads insulin delivery tech to MannKindZealand Pharma hasfounda buyer for its V-Go insulin delivery device. Weeks after lackluster sales led it to seek a partner for the device, Zealand has agreed to offload the technology and associated2022/5/18
-
Buffett's Berkshire backs out of AbbVie, Bristol Myers Squibb holdingsAfter a gung-ho push into biopharma at the peak of the COVID-19 pandemic, Warren Buffett’s investment shop Berkshire Hathaway—more comfortable with tech stocks like Amazon and Apple—has hived off two2022/5/18
-
Valneva's COVID-19 vaccine faces uncertain future after Europe cancels supply contractWith Valneva’s inactivated COVID-19 vaccine candidate stalled in the regulatory process, the European Commission haspulledthe plug on its advance purchase agreement for the shot. Oncebelievedto2022/5/16
-
3rd time lucky? ScPharmaceuticals gets decision date for twice-rejected on-body drug delivery productScPharmaceuticals has an important new date for its calendar. With the FDAacceptingan approval filing for its on-body infusor heart failure therapy, scPharmaceuticals is set to learn whether the cand2022/5/16
-
Johnson & Johnson taps insiders to lead consumer health group after 2023 separationJohnson & Johnson is making headway toward its consumer health separation, and on Wednesday the company revealed the group's planned leadership. Thibaut Mongon will2022/5/12